Efficacy Of Bendamustine and Rituximab In Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

被引：0
|
作者：
Kataeva, Elena
Golenkov, Anatoly
Triphonova, Elena
Dudina, Galina
Mitina, Tatyana
Lutskaya, Tatyana
Vysotskaya, Ludmila
Chernykh, Yulliya
Zakharov, Sergey
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5312.5312
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5312
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Bfr (bendamustine, fludarabine, rituximab) Nonmyeloablative Allogeneic Conditioning Improves Survival in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).
    Khouri, Issa F.
    Saliba, Rima M.
    Ledesma, Celina
    Jabbour, Elias J.
    Turturro, Francesco
    Alatrash, Gheath
    Ahmed, Sairah
    Oran, Betul
    Patel, Krina K.
    Olson, Amanda
    Marin, David
    Popat, Uday R.
    Suki, Tina S.
    Jorgensen, Jeffrey L.
    Medeiros, L. Jeffrey
    Gulbis, Alison M.
    BLOOD, 2015, 126 (23)
  • [22] Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia
    Wierda, W
    O'Brien, S
    Wen, S
    Faderl, S
    Garcia-Manero, G
    Thomas, D
    Do, KA
    Cortes, J
    Koller, C
    Beran, M
    Ferrajoli, A
    Giles, F
    Lerner, S
    Albitar, M
    Kantarjian, H
    Keating, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) : 4070 - 4078
  • [23] The HELIOS trial protocol: a Phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia
    Hallek, Michael
    Kay, Neil E.
    Osterborg, Anders
    Chanan-Khan, Asher A.
    Mahler, Michelle
    Salman, Mariya
    Wan, Ying
    Sun, Steven
    Zhuang, Sen Hong
    Howes, Angela
    FUTURE ONCOLOGY, 2015, 11 (01) : 51 - 59
  • [24] EFFICACY OF COMBINATION FLUDARABINE AND ALEMTUZUMAB IN PATIENTS WITH RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
    Zagoskina, T.
    Zotina, E.
    Malykh, O.
    HAEMATOLOGICA, 2012, 97 : 305 - 305
  • [25] Efficacy of rituximab in combination with steroids in refractory chronic lymphocytic leukemia
    Quinn, J. P.
    Mohamedbhai, S.
    Chipperfield, K.
    Treacy, M.
    D'Sa, S.
    Nathwani, A. C.
    LEUKEMIA & LYMPHOMA, 2008, 49 (10) : 1995 - 1998
  • [26] BENDAMUSTINE MONOTHERAPY IN ELDERLY PATIENTS AFFECTED BY RELAPSED OR REFRACTORY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
    Lucania, A.
    Esposito, M.
    Della Cioppa, P.
    Improta, S.
    Mastrullo, L.
    HAEMATOLOGICA, 2015, 100 : 74 - 74
  • [27] ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
    Ghia, Paolo
    Pluta, Andrzej
    Wach, Malgorzata
    Lysak, Daniel
    Kozak, Tomas
    Simkovic, Martin
    Kaplan, Polina
    Kraychok, Iryna
    Illes, Arpad
    de la Serna, Javier
    Dolan, Sean
    Campbell, Phillip
    Musuraca, Gerardo
    Jacob, Abraham
    Avery, Eric
    Lee, Jae Hoon
    Liang, Wei
    Patel, Priti
    Quah, Cheng
    Jurczak, Wojciech
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (25) : 2849 - +
  • [28] Bendamustine in chronic lymphocytic leukemia and refractory lymphoma
    Rummel, Mathias J.
    SEMINARS IN HEMATOLOGY, 2008, 45 (03) : S7 - S10
  • [29] Detailed Safety Analysis of Venetoclax Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
    Brander, Danielle M.
    Choi, Michael Y.
    Roberts, Andrew W.
    Ma, Shuo
    Lash, L. Leanne
    Verdugo, Maria
    Zhu, Ming
    Kim, Su Young
    Seymour, John F.
    BLOOD, 2016, 128 (22)
  • [30] Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group
    Bergmann, Manuela A.
    Goebeler, Maria E.
    Herold, Michael
    Emmerich, Bertold
    Wilhelm, Martin
    Ruelfs, Corinna
    Boening, Lothar
    Hallek, Michael J.
    HAEMATOLOGICA, 2005, 90 (10) : 1357 - 1364
12345